A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
Clinical trial NCT04253015 · RECRUITING
Trial details
- NCT number
- NCT04253015
- Sponsor
- RECORDATI GROUP
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-30
- Primary completion
- 2032-03-31
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.